Biologic (Decay-Corrected) Data for 111In-Ibritumomab Tiuxetan
| Site | Fraction initial uptake (±SD) | Retention half-time (h ± SD) | Residence time (h ± SD) |
|---|---|---|---|
| Heart contents | 0.0640 ± 0.0212 | 48.1 ± 15.8 | 1.18 ± 0.557 |
| Kidneys | 0.0262 ± 0.00780 | 106 ± 45.7 | 1.40 ± 0.351 |
| Liver | 0.145 ± 0.0253 | 141 ± 76.0 | 12.9 ± 4.92 |
| Lungs | 0.0394 ± 0.0126 | 46.6 ± 11.7 | 1.41 ± 0.904 |
| Red marrow | 0.146 ± 0.0283 | 286 ± 347 | 11.7 ± 4.52 |
| Spleen | 0.0417 ± 0.0143 | 106 ± 56.5 | 1.63 ± 0.814 |
| Testes | 0.00192 ± 0.00133 | 67.4 ± 6.86 | 0.163 ± 0.0650 |
| Whole body | 1.0 | 380 ± 162 | |
| Remainder of whole body | 0.535 ± 0.0995 | >400 (long) | 51.8 ± 16.2 |